| Autor: |
Angrist, B., Ain, M., Rotrosen, J., Gershon, S., Halpern, F. S., Sachar, E. J. |
| Zdroj: |
Journal of Neural Transmission; December 1979, Vol. 44 Issue: 4 p249-262, 14p |
| Abstrakt: |
Summary Low doses of the dopamine agonist ET-495 were administered to non-psychotic volunteer subjects by slow intravenous infusion, followed by a bolus of 1.5–2.5 mg haloperidol. ET-495 caused progressive dysphoria and sedation (in some cases, light sleep), effects believed to be mediated by dopaminergic inhibition. However, ET-495 also elevated growth hormone and suppressed prolactin, typical responses to dopamine agonist activity. Haloperidol reversed both the sedation and prolactin suppression induced by ET-495. These findings suggest: (1) that the sedation and hormonal responses were produced by stimulation of dopamine receptors; (2) that neurotransmitter systems mediating behavioral and neuroendocrine regulation may have differential neuropharmacological characteristics. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink